BioMedEcon Reports 200% Higher Outpatient Medical Costs Among Patients With Obsessive-Compulsive Disorder Compared To Matched Patients With Depression

BioMedEcon, a leading provider of health economics and outcomes research, presented findings from a landmark nine-year retrospective claims analysis that compared the median per-patient health care costs for patients with obsessive-compulsive disorder (OCD) versus depression. This study, supported by Jazz Pharmaceuticals, Inc., was presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) annual meeting on May 3-7, in Toronto.